Isabel Alfradique-Dunham

Medicine & Life Sciences

1. Parkinson Disease 100%
2. Stroop Test 78%
3. Movement Disorders 75%
4. Juvenile Myoclonic Epilepsy 46%
5. Color 46%
6. Progressive Supranuclear Palsy 41%
7. Lewy Bodies 40%
8. Negotiating 37%
9. Comparative Genomic Hybridization 37%
10. Dystonia 36%
11. Genome-Wide Association Study 32%
12. Exome 31%
13. Myoclonic Epilepsy 28%
14. Dementia 25%
15. Nucleotides 25%
16. Gait 24%
17. Pathology 24%
18. Seizures 24%
19. Alcohols 23%
20. Meta-Analysis 23%
21. Valproic Acid 22%
22. Tremor 20%
23. Alleles 15%
24. Precipitating Factors 13%
25. Lamotrigine 13%
26. Epileptic Syndromes 13%
27. Myoclonus 12%
28. Mental Status and Dementia Tests 12%
29. Posture 11%
30. Essential Tremor 10%
31. Diagnostic Errors 10%
32. Anticonvulsants 9%
33. Neuroimaging 9%
34. Lewy Body Disease 9%
35. Baclofen 8%
36. Therapeutics 8%
37. Mental Disorders 8%
38. Neuropathology 8%
39. Botulinum Toxins 8%
40. Deep Brain Stimulation 8%
41. Genome 7%
42. Parkinson disease 3 6%
43. Linear Models 6%
44. Ink 5%
45. Recurrence 5%
46. Age of Onset 5%
47. Dopa-Responsive Dystonia 5%
48. Wearable Electronic Devices 5%
49. Heterozygote 5%
50. DNA Replication 5%